BRD4 and cancer: In BRD4-dependent cancer cells, key pro-tumorigenic genes display marked enrichment for BRD4 at enhancers and super-enhancers, DNA regions defined by histone hyperacetylation modifications, including histone 3 lysine 27 acetylation (H3K27ac)12,13.